Company Encyclopedia
View More
name
Hyperion DeFi
HYPD.US
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals.
4.514 T
HYPD.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking95/183
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-70.89%E
    • Profit Margin-7385.53%E
    • Gross Margin100.00%A
  • Growth ScoreA
    • Revenue YoY984.82%A
    • Net Profit YoY30.23%B
    • Total Assets YoY263.18%A
    • Net Assets YoY1802.37%A
  • Cash ScoreB
    • Cash Flow Margin-1.31%D
    • OCF YoY984.82%A
  • Operating ScoreE
    • Turnover0.01E
  • Debt ScoreA
    • Gearing Ratio14.54%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hyperion DeFi | 10-Q: FY2025 Q3 Revenue: USD 302.51 K

    LB filings·
    US
    HYPD
    +9.97%
    LB filings·
    US
    HYPD
    +9.97%

    Hyperion DeFi Inc. Regains Nasdaq Compliance After Meeting Minimum Equity Requirement

    Hyperion DeFi Inc. has announced that it has regained compliance with Nasdaq's minimum equity requirement of $2,500,000, following a notice received on April 29, 2025, regarding its previous non-compliance. As of September 2, 2025, Nasdaq confirmed that Hyperion DeFi meets the necessary standards, allowing the company to maintain its listing on the Nasdaq Stock Market. This update is significant for the company's standing in the market.

    Reuters·
    US
    HYPD
    +9.97%
    Reuters·
    US
    HYPD
    +9.97%

    Hyperion DeFi | 8-K: FY2025 Q2 Revenue Misses Estimate at USD 0

    LB filings·
    US
    HYPD
    +9.97%
    LB filings·
    US
    HYPD
    +9.97%

    Hyperion DeFi | 10-Q: FY2025 Q2 Revenue Misses Estimate at USD 0

    LB filings·
    US
    HYPD
    +9.97%
    LB filings·
    US
    HYPD
    +9.97%

    Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

    Company to host an investor conference call and webcast at 4:30 pm ET Company to host an investor conference call and webcast at 4:30 pm ET ...

    GlobeNewswire·
    US
    HYPD
    +9.97%
    GlobeNewswire·
    US
    HYPD
    +9.97%
    © 2025 Longbridge｜Disclaimer